Radiation-Sparing Treatments for Cervical Cancer in Developing Countries
Author Information
Author(s): Candelaria Myrna, Cetina Lucely, Garcia-Arias Alicia, Lopez-Graniel Carlos, de la Garza Jaime, Robles Elizabeth, Duenas-Gonzalez Alfonso
Primary Institution: Instituto Nacional de Cancerología, Mexico City, Mexico
Hypothesis
Cervical cancer patients in developing countries need newer treatment options that do not rely on radiation.
Conclusion
Radiation-sparing management options like total mesometrial resection and neoadjuvant chemotherapy could significantly reduce the need for radiation in cervical cancer treatment.
Supporting Evidence
- Cervical cancer is the seventh most frequent cancer worldwide, with over 80% of cases in developing countries.
- Radiation therapy is often not accessible in developing countries due to financial constraints and lack of qualified personnel.
- Total mesometrial resection could eliminate the need for adjuvant radiation in some patients.
- Neoadjuvant chemotherapy could avoid the use of adjuvant radiation in around 85% of patients.
Takeaway
Some treatments for cervical cancer can help patients avoid radiation, which is often hard to get in poorer countries. This could help more people get the care they need.
Methodology
The review discusses various treatment options for cervical cancer, focusing on those that can be implemented in developing countries.
Limitations
The review does not provide specific data on the effectiveness of the proposed treatments compared to standard radiation therapy.
Participant Demographics
The review focuses on cervical cancer patients in developing countries, where access to radiation therapy is limited.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website